• Minoru Fukuda, Yasushi Obase, Naoyuki Miyashita, Dai Shibata, Kenji Yoshida, Yuichiro Mori, Keiji Mouri, Koichiro Yoshida, Yoshihiro Kobashi, Yoshito Niki, and Mikio Oka.
• Division of Respiratory Diseases, Department of Medicine and Kawasaki Medical School, Okayama, Japan. mifukuda258@nifty.com
• Anticancer Res. 2006 Jan 1;26(1B):565-7.

AbstractAirway and vascular constrictions are expected problems for lung cancer patients. The clinical course of a patient in whom stents were inserted in 3 constriction regions is reported. A 72-year-old man with advanced primary lung cancer (squamous cell carcinoma stage IIIB) developed suffocating constriction of the trachea and showed superior vena cava (SVC) syndrome. Self-expandable metal stents were inserted into the trachea, SVC and left subclavian vein and the patient was treated by radiotherapy and weekly irinotecan. Within 5 months of treatment, complete local control was achieved and there was no reconstriction. Both endobronchial and endovascular stenting prior to antitumor therapy may be beneficial in the treatment of locally advanced cases of lung cancer.

25 keywords...

hide…